The future of MRI in radiation therapy: challenges and opportunities for the MR community

被引:25
作者
Goodburn, Rosie J. [1 ,2 ]
Philippens, Marielle E. P. [3 ]
Lefebvre, Thierry L. [4 ,5 ]
Khalifa, Aly [6 ]
Bruijnen, Tom [3 ]
Freedman, Joshua N. [7 ]
Waddington, David E. J. [8 ]
Younus, Eyesha [9 ]
Aliotta, Eric [10 ]
Meliado, Gabriele [11 ]
Stanescu, Teo [12 ,13 ]
Bano, Wajiha [1 ,2 ]
Fatemi-Ardekani, Ali [14 ,15 ,16 ]
Wetscherek, Andreas [1 ,2 ]
Oelfke, Uwe [1 ,2 ]
van den Berg, Nico [3 ]
Mason, Ralph P. [17 ]
van Houdt, Petra J. [18 ]
Balter, James M. [19 ]
Gurney-Champion, Oliver J. [20 ]
机构
[1] Inst Canc Res, Joint Dept Phys, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
[3] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands
[4] Univ Cambridge, Dept Phys, Cambridge, England
[5] Univ Cambridge, Canc Res UK Cambridge Res Inst, Cambridge, England
[6] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[7] Elekta Ltd, Crawley, England
[8] Univ Sydney, Sydney Sch Hlth Sci, ACRF Image X Inst, Fac Med & Hlth, Sydney, NSW, Australia
[9] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Dept Med Phys, Toronto, ON, Canada
[10] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[11] Azienda Osped Univ Integrata Verona, Unita Operat Complessa Fis Sanit, Verona, Italy
[12] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[13] Univ Hlth Network, Princess Margaret Canc Ctr, Med Phys, Toronto, ON, Canada
[14] Jackson State Univ, Dept Phys, Jackson, MS USA
[15] SpinTecx, Jackson, MS USA
[16] Community Hlth Syst CHS Canc Network, Dept Radiat Oncol, Jackson, MS USA
[17] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA
[18] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[19] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[20] Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Imaging & Biomarkers, Amsterdam, Netherlands
基金
美国国家卫生研究院;
关键词
future; MR; radiation therapy; ISMRM workshop; GUIDED RADIOTHERAPY; CLINICAL IMPLEMENTATION; ADAPTIVE RADIOTHERAPY; HYPERPOLARIZED HE-3; IMAGING BIOMARKER; COMPUTED-TOMOGRAPHY; VOLUME DELINEATION; RESPIRATORY MOTION; CANCER-PATIENTS; NEURAL-NETWORK;
D O I
10.1002/mrm.29450
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Radiation therapy is a major component of cancer treatment pathways worldwide. The main aim of this treatment is to achieve tumor control through the delivery of ionizing radiation while preserving healthy tissues for minimal radiation toxicity. Because radiation therapy relies on accurate localization of the target and surrounding tissues, imaging plays a crucial role throughout the treatment chain. In the treatment planning phase, radiological images are essential for defining target volumes and organs-at-risk, as well as providing elemental composition (e.g., electron density) information for radiation dose calculations. At treatment, onboard imaging informs patient setup and could be used to guide radiation dose placement for sites affected by motion. Imaging is also an important tool for treatment response assessment and treatment plan adaptation. MRI, with its excellent soft tissue contrast and capacity to probe functional tissue properties, holds great untapped potential for transforming treatment paradigms in radiation therapy. The MR in Radiation Therapy ISMRM Study Group was established to provide a forum within the MR community to discuss the unmet needs and fuel opportunities for further advancement of MRI for radiation therapy applications. During the summer of 2021, the study group organized its first virtual workshop, attended by a diverse international group of clinicians, scientists, and clinical physicists, to explore our predictions for the future of MRI in radiation therapy for the next 25 years. This article reviews the main findings from the event and considers the opportunities and challenges of reaching our vision for the future in this expanding field.
引用
收藏
页码:2592 / 2608
页数:17
相关论文
共 186 条
[1]   A systematic literature review looking for the definition of treatment burden [J].
Alsadah, Ahmed ;
van Merode, Tiny ;
Alshammari, Riyadh ;
Kleijnen, Jos .
HELIYON, 2020, 6 (04)
[2]  
[Anonymous], 2021, MHRA Internet
[3]   Oxygen-Sensitive MRI: A Predictive Imaging Biomarker for Tumor Radiation Response? [J].
Arai, Tatsuya J. ;
Yang, Donghan M. ;
Campbell, James W. ;
Chiu, Tsuicheng ;
Cheng, Xinyi ;
Stojadinovic, Strahinja ;
Peschke, Peter ;
Mason, Ralph P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05) :1519-1529
[4]   Deep learning how to fit an intravoxel incoherent motion model to diffusion-weighted MRI [J].
Barbieri, Sebastiano ;
Gurney-Champion, Oliver J. ;
Klaassen, Remy ;
Thoeny, Harriet C. .
MAGNETIC RESONANCE IN MEDICINE, 2020, 83 (01) :312-321
[5]   Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac [J].
Barnes, Helen ;
Alexander, Sophie ;
Bower, Lorna ;
Ehlers, Jakob ;
Gani, Cihan ;
Herbert, Trina ;
Lawes, Rebekah ;
Moller, Pia Krause ;
Morgan, Toby ;
Nowee, Marlies E. ;
Smith, Gillian ;
van Triest, Baukelien ;
Tyagi, Neelam ;
Whiteside, Lee ;
McNair, Helen .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 30 :31-37
[6]   Radiotherapy activities and technological equipment in Veneto, Italy: a report from the Rete Radioterapica Veneta [J].
Bellometti, Simona ;
Nube, Gabriele ;
Alongi, Filippo ;
Baiocchi, Cristina ;
Corti, Luigi ;
Di Biase, Saide ;
Fiorica, Francesco ;
Gava, Alessandro ;
Iannone, Tiziana ;
Abu Rumeileh, Imad ;
Mazzarotto, Renzo ;
Testolin, Alessandro ;
Mandoliti, Giovanni .
RADIOLOGIA MEDICA, 2021, 126 (04) :623-629
[7]  
Billot B, 2021, Arxiv, DOI arXiv:2003.01995
[8]   Characterization of imaging latency for real-time MRI-guided radiotherapy [J].
Borman, P. T. S. ;
Tijssen, R. H. N. ;
Bos, C. ;
Moonen, C. T. W. ;
Raaymakers, B. W. ;
Glitzner, M. .
PHYSICS IN MEDICINE AND BIOLOGY, 2018, 63 (15)
[9]   Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate [J].
Burman, C ;
Chui, CS ;
Kutcher, G ;
Leibel, S ;
Zelefsky, M ;
LoSasso, T ;
Spirou, S ;
Wu, QW ;
Yang, J ;
Stein, J ;
Mohan, R ;
Fuks, Z ;
Ling, CC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :863-873
[10]  
Burnet Neil G, 2004, Cancer Imaging, V4, P153, DOI 10.1102/1470-7330.2004.0054